Pharvaris president exercises, sells 15K shares
Pharvaris’ president executed a scheduled option exercise and matching share sale under a Rule 10b5-1 plan, leaving a sizable option position outstanding.
Rhea-AI Filing Summary
Pharvaris N.V. (PHVS) reported that President Lu Peng exercised options to acquire 15,000 shares of Common Stock at $2.59 per share on September 8, 2026 and, in a related cashless transaction under a Rule 10b5-1 trading plan, sold 15,000 shares at a weighted average of $40.6756 per share. Following these transactions, options to purchase 43,308 shares at $2.59 remain outstanding, expiring on February 3, 2030.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 15,000 shares
Net Sell
3 txns
Insider
Lu Peng
Role
President
Sold
15,000 shs ($610K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Common Stock F1 | 15,000 | $2.59 | $39K |
| Sale | Common Stock F1, F2 | 15,000 | $40.6756 | $610K |
| holding | Stock Option (Right to Buy) F3 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 65,179 shares (Direct);
Stock Option (Right to Buy) — 43,308 contracts for 15,000 underlying shares (Direct)
Footnotes (3)
- F1. This is a scheduled exercise and sale from 10b5-1 trading plan.
- F2. The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $40.50 to $40.80. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F3. 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.
Key Figures
Shares acquired via option exercise: 15,000 shares
Option exercise price: $2.59 per share
Shares sold: 15,000 shares
+5 more
8 metrics
Shares acquired via option exercise
15,000 shares
Options on Pharvaris Common Stock exercised on September 8, 2026
Option exercise price
$2.59 per share
Exercise of 15,000 options on September 8, 2026
Shares sold
15,000 shares
Sale of Common Stock on September 8, 2026 linked to the option exercise
Weighted average sale price
$40.6756 per share
Sales on September 8, 2026 under Rule 10b5-1 plan; individual prices $40.50–$40.80
Remaining stock options
43,308 options
Options to buy Pharvaris Common Stock outstanding after the reported transactions
Remaining option exercise price
$2.59 per share
Exercise price for 43,308 remaining options
Option expiration date
February 3, 2030
Expiration of the remaining options held by Lu Peng
Underlying shares for remaining options
15,000 shares
Underlying Pharvaris Common Stock referenced for one reported option position
Key Terms
Rule 10b5-1 trading plan, cashless exercise transaction, weighted average sale price, vesting
4 terms
Rule 10b5-1 trading plan regulatory
"shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
cashless exercise transaction financial
"The shares were sold in connection with the exercise of stock options in a cashless exercise transaction."
weighted average sale price financial
"The reported price represents a weighted average sale price for shares sold in multiple transactions"
vesting financial
"25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What insider transactions did PHVS President Lu Peng report on September 8, 2026?
Lu Peng exercised options to acquire 15,000 Pharvaris (PHVS) shares at $2.59 per share and, in a related cashless transaction, sold 15,000 shares at a weighted average price of $40.6756 per share on September 8, 2026.
Were the latest PHVS insider transactions by Lu Peng under a Rule 10b5-1 trading plan?
Yes. The filing states the exercise and sale were scheduled transactions under a Rule 10b5-1 trading plan, and describes the sale as made pursuant to such a plan with multiple trades combined into a weighted average price.
What prices were involved in Lu Peng’s September 8, 2026 PHVS transactions?
The options were exercised at $2.59 per share. The related sale of 15,000 shares was reported at a weighted average price of $40.6756 per share, with individual sale prices ranging from $40.50 to $40.80 per share.
How many PHVS stock options does Lu Peng hold after the reported transactions?
After the September 8, 2026 activity, Lu Peng holds options covering 43,308 shares of Pharvaris Common Stock at an exercise price of $2.59 per share, with an expiration date of February 3, 2030.
What is meant by a cashless exercise in Lu Peng’s PHVS Form 4?
The filing explains that shares were sold in connection with the exercise of stock options in a cashless exercise transaction, meaning sale proceeds from the exercised shares were used to cover the option exercise costs rather than paying cash separately.
AI-generated analysis. How Rhea-AI works. Not financial advice.
